Regenerative Medicine for Hip Osteoarthritis Overview

Regenerative Medicine for Hip Osteoarthritis: An Integrative and Evidence-Based Approach

Abstract

Hip osteoarthritis (OA) represents a significant and growing global health concern, profoundly impacting individuals’ quality of life and longevity. This educational post explores the increasing prevalence of hip OA, as documented by the Global Burden of Disease study, and its serious implications, including an elevated risk of all-cause and cardiovascular mortality. I will guide you through the complex anatomy of the hip region, detailing the common clinical presentations and diagnostic physical exam maneuvers essential for accurate assessment. We will then delve into a comprehensive overview of evidence-based treatment options, from the foundational roles of physical therapy and integrative chiropractic care to a comparative analysis of corticosteroid injections and biologic therapies such as platelet-rich plasma (PRP). Drawing upon the latest systematic reviews and my clinical observations, we will discuss the efficacy, timing, and long-term benefits of these interventions, highlighting how a multi-faceted, patient-centered approach can effectively manage pain, restore function, and improve overall health outcomes.

Hello, I’m Dr. Alex Jimenez. With my background as a Doctor of Chiropractic, Advanced Practice Registered Nurse, and board-certified Family Nurse Practitioner, along with extensive training in functional medicine, I am passionate about bridging the gap between cutting-edge research and practical, patient-centered care. Today, I want to take a deeper dive into a condition I see frequently in my practice: hip osteoarthritis (OA). This isn’t just a matter of aches and pains; it’s a serious health issue with far-reaching consequences. My goal is to walk you through the latest findings from leading researchers, presenting them through the lens of modern, evidence-based methods, and to show how an integrative approach is key to successful outcomes.

The Growing Global Burden of Hip Osteoarthritis

We often feel like we’re seeing a lot of hip OA because, frankly, we are. But the scale of the problem is even larger than many of us realize. The Global Burden of Disease study, an ongoing, decades-long project, provided some startling insights in its 2019 report. Analyzing data from 200 countries, researchers found that between 1990 and 2019, the global prevalence of hip OA more than doubled, soaring from 740,000 cases to 1.6 million (GBD 2019 Diseases and Injuries Collaborators, 2020).

What’s more, the age-standardized prevalence rate also climbed from 17 to 18.7 per 100,000 people. When we look at the geographical patterns, we see particularly high rates in North America, Europe, Australia, and parts of South America. Interestingly, high-income regions in North America show the highest rates overall, suggesting that economic and lifestyle factors, perhaps related to specific types of physical activity or inactivity, play a significant role.

The impact of this condition extends far beyond joint pain. Symptomatic arthritis of the hip and knee leads to a reduction in physical activity, which, in turn, is associated with a 20% higher age-adjusted mortality rate. A 2015 study with a 16-year follow-up period starkly illustrated this point:

• Individuals with hip OA had a 14% increase in all-cause mortality.
• They also faced a 24% increase in cardiovascular disease mortality (Nüesch et al., 2015).

These statistics are a powerful reminder that the immobility and pain caused by hip OA are not just a burden on daily life; they pose a real threat to a person’s overall health and longevity. In my clinical practice, I see this firsthand. A patient who can no longer walk their dog, play with their grandchildren, or engage in a favorite hobby isn’t just losing an activity; they are losing a vital part of their physical and mental well-being, which can spiral into a cycle of decline.

The Complex Anatomy of the Hip Region

To effectively treat hip pain, we must first appreciate the intricate anatomy of the area. The hip is not an isolated joint but a complex functional unit.

• Bony Structures: The core of the joint is the articulation between the femur (thigh bone) and the acetabulum (the socket in the pelvis). Other key landmarks include the greater trochanter, where important gluteal muscles attach, and the nearby sacroiliac (SI) joint. All these structures work together, and dysfunction in one can create a cascade of problems elsewhere.
• Soft Tissues: Layered atop this bony foundation is a dense network of muscles, ligaments, tendons, nerves, and blood vessels. Any of these can be a source of pain, complicating the diagnostic picture.

The classic clinical presentation of intra-articular hip joint pathology (pain coming from within the joint itself) is a sharp, pinching sensation, typically felt in the anterior groin and inner thigh. Patients often describe this using the “C-sign”—cupping their hand in a “C” shape around the side of their hip.

However, pain referral patterns can be misleading. While anterior pain (the blue area in the diagram below) is most common for hip joint issues, about 10% of cases can present with posterior or buttock pain (the green area). I’ve had numerous patients come to me who were being treated for SI joint dysfunction, sciatica, or hamstring issues without success. A closer look revealed that the root cause was underlying hip joint pathology that had been missed. This is a critical clinical pearl: if a patient with posterior hip pain isn’t responding to treatment, always consider the hip joint as a potential primary driver.

The Diagnostic Hip Examination

A thorough physical exam is paramount for pinpointing the source of pain. While we assess all ranges of motion, internal and external rotation are often the most revealing for hip joint pathology. A healthy hip typically has around 30-40 degrees of internal rotation and 40-60 degrees of external rotation. Significant limitations or pain with these movements are strong indicators of a problem within the joint.

Several specific orthopedic tests help us confirm our suspicions:

• Log Roll Test: With the patient lying on their back, I gently roll their leg inward and outward. This is a very good test for hip joint irritability with minimal stress on other structures.
• FABER Test (Flexion, Abduction, External Rotation): This maneuver, also known as the Patrick’s test, is excellent for provoking pain from the hip joint. However, it can also stress the SI joint, so it’s crucial to ask the patient, “Where exactly are you feeling the pain?” Location is key to differentiating the source.
• FADIR Test (Flexion, Adduction, Internal Rotation): This is perhaps our most useful test for detecting intra-articular hip pathology, particularly femoroacetabular impingement (FAI). Even if it reproduces pain in a lateral or posterior location, a positive test raises my suspicion for a hip joint problem.

An Integrative Framework for Treatment

When it comes to treating hip OA, there is one non-negotiable foundation: physical therapy and biomechanical correction. I cannot emphasize this enough. The hip joint is the central pillar, but the surrounding musculature provides the dynamic stability and support. If you reduce the pain without addressing the underlying biomechanical faults—weak glutes, tight hip flexors, poor core control—the problem will inevitably return. The pain relief from any injection will be temporary if the faulty mechanics that caused the problem in the first place are not corrected.

In my practice, integrative chiropractic care plays a crucial role in this process. We focus on restoring proper movement patterns not just in the hip, but in the entire kinetic chain—from the lumbar spine and pelvis down to the knees and ankles. Through specific adjustments, soft-tissue therapies, and targeted exercises, we work to unload the irritated hip joint and build a strong, resilient foundation to support it in the long term.

Corticosteroid Injections

Corticosteroids have long been a mainstay for managing inflammatory joint pain. They can be delivered via ultrasound or fluoroscopic guidance directly into the hip joint. The American Academy of Orthopaedic Surgeons gives this treatment a moderate recommendation for short-term pain relief. It can also be used as a diagnostic tool; if a patient’s pain is completely resolved after a lidocaine/corticosteroid injection, it confirms the hip joint as the primary pain generator.

A 2021 systematic review of 16 randomized controlled trials (RCTs) involving nearly 1,700 patients confirmed this. It found that steroid injections were significantly more effective than a placebo at providing pain relief at the three-month mark, but this advantage disappeared by six months (Kattih et al., 2021). The conclusion is clear: corticosteroids can provide effective, but temporary, relief.

The Promise of Biologics: Platelet-Rich Plasma (PRP)

This is where biologic therapies, like Platelet-Rich Plasma (PRP), enter the conversation. PRP involves concentrating a patient’s own platelets from a blood sample and injecting them into the joint. These platelets are rich in growth factors and signaling proteins that can help modulate the inflammatory environment and stimulate a healing response.

A pooled analysis of eight RCTs found that PRP significantly reduced pain at multiple time points (Belk et al., 2021). Interestingly, the review noted:

• A single PRP injection often provided greater pain reduction than a series of multiple injections.
• Lower injection volumes (under 15 mL) tended to perform better than higher volumes. The hip is a small, tight joint capsule, and over-distending it can be intensely painful and counterproductive. In my experience, a volume of around 5-6 mL is typically well-tolerated and effective.

Head-to-Head: Corticosteroids vs. PRP

So, how do these treatments stack up against each other? A large systematic review of 11 studies, including over 1,000 patients, provided a direct comparison. The findings were consistent with the broader body of evidence:

• Corticosteroids provided effective short-term pain relief.
• PRP demonstrated the most significant reduction in pain at the six-month mark (Hohmann et al., 2022).

This confirms what many of us see in practice: biologics take longer to exert their effects—often 6-8 weeks or more—but their benefits are more durable. They aren’t just masking inflammation; they are working to change the joint’s biological environment for the better.

A Clinical Case Study: The Interplay of Hip and Spine

The complexity of this region means that pain is often multifactorial. I want to share the case of a 22-year-old college football linebacker who came to my clinic.

He had been battling what was diagnosed as “back pain” for six months. He had undergone multiple epidural steroid injections, medial branch blocks, and even injections for sciatica, all with no benefit. His hip exam was profoundly limited, with only 15 degrees of internal rotation and a positive FABER test. His spine exam, ironically, was normal.

An MRI of his lumbar spine did show a large L5-S1 disc herniation, which had been the focus of all his previous treatments. However, no one had ever ordered simple hip X-rays. We obtained an AP and frog-leg view, which immediately revealed a cam lesion—a bony overgrowth on the femoral head-neck junction characteristic of FAI. An MRI of his hip confirmed the bony abnormality and showed associated cartilage damage.

Our treatment plan was integrative and sequential:

1. Foundation First: We immediately started him on physical therapy focused on hip mobility, glute activation, and specific core strengthening to stabilize his pelvis and lumbar spine.
2. Diagnostic & Therapeutic Injection: Because he was under pressure to perform, we administered a diagnostic corticosteroid injection into his hip joint. This completely eliminated his pain, confirming the hip as the primary pain source.
3. Regenerative Therapy: Three months later, during his off-season, we performed a PRP injection into the hip joint to promote longer-term healing and anti-inflammatory effects.

The result? He completed his next three collegiate seasons with no time lost due to either his hip or his lumbar spine. This case perfectly illustrates how easily hip pathology can be misdiagnosed as a spine issue and underscores the importance of a comprehensive approach that addresses both the diagnosis and the underlying biomechanics.

Future Directions and My Clinical Approach

The field of regenerative medicine is constantly evolving. While we have robust data for the knee, we are still refining our protocols for the hip. Key questions we are working to answer include:

• What is the optimal platelet dosing?
• What is the ideal frequency of injections? (Current data suggests a single injection may be superior to multiple).
• How can we best leverage different components of the blood? For instance, platelet-poor plasma (PPP), which is often discarded, contains anti-inflammatory proteins that could have long-term benefits.

In my clinic, I use a benchtop processing system that allows me to customize the treatment for each patient. For a hip injection, I can prepare a 6 mL sample of highly concentrated PRP. If I choose, I can also harvest a few milliliters of the platelet-poor plasma and inject it alongside the PRP to leverage its unique anti-inflammatory properties, providing both immediate modulation and a long-term regenerative signal.

Ultimately, managing hip OA effectively requires us to look beyond the joint itself. It demands a holistic, evidence-based strategy that integrates biomechanical correction through physical therapy and chiropractic care with advanced, targeted interventions like PRP. By taking this comprehensive journey with our patients, we can not only alleviate their pain but also restore their function, improve their overall health, and give them their lives back.

References

Belk, J. W., Kraeutler, M. J., Houck, D. A., Goodrich, J. A., Dragoo, J. L., & McCarty, E. C. (2021). Platelet-rich plasma versus hyaluronic acid for knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials. The American Journal of Sports Medicine, 49(1), 249–260. https://doi.org/10.1177/0363546520909397

GBD 2019 Diseases and Injuries Collaborators. (2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet, 396(10258), 1204–1222. https://doi.org/10.1016/S0140-6736(20)30925-9

Hohmann, E., Tetsworth, K., & Glatt, V. (2022). Is platelet-rich plasma effective for the treatment of hip osteoarthritis? A systematic review and meta-analysis of randomized controlled trials. The Journal of Arthroplasty, 37(6), 1221-1229.e1. https://doi.org/10.1016/j.arth.2022.02.012

Kattih, M. Z., El-Haddad, S. H., & Al-Kashmiri, A. (2021). Intra-articular corticosteroid injection for the treatment of hip osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Journal of Orthopaedics and Traumatology, 22(1), 2. https://doi.org/10.1186/s10195-020-00569-8

Nüesch, E., Dieppe, P., Reichenbach, S., Williams, S., Iff, S., & Jüni, P. (2015). All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study. BMJ, 342, d1165. https://doi.org/10.1136/bmj.d1165